VIJAYA DIAGNOSTIC CEN Latest Share Price (VIJAYA)
TODAY IN ONE LINE
VIJAYA slipped 0.8% on light volume, lagging Nifty's 0.3% move.
With a market cap of ₹15,528.09 Cr., it trades at a P/E of 82.71. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
VIJAYA DIAGNOSTIC CEN flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 38.0% YoY
- ●High Capital EfficiencyROCE of 22.3% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 18.9%
- ●Healthy Operating MarginsOPM is structurally strong at 34.9%
- ●High Promoter HoldingPromoters hold 52.5% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 5.4% YoY
- ●Expensive ValuationTrading at a high P/E ratio of 81.4x
Latest VIJAYA DIAGNOSTIC CEN News
What changed recently?
Recent events, corporate actions, and announcements.
VIJAYA DIAGNOSTIC CEN valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for VIJAYA DIAGNOSTIC CEN, framed against the sector median so the premium or discount is obvious at a glance.
VIJAYA DIAGNOSTIC CEN trades at a P/E of 82.71× and P/B of 16.21×, against the Healthcare sector median P/E of 46.81×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
VIJAYA DIAGNOSTIC CEN technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for VIJAYA DIAGNOSTIC CEN — derived from the latest tape, not yesterday's close.
VIJAYA DIAGNOSTIC CEN last traded at ₹1,513.6 with an intraday range of ₹1,504–₹1,540 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1513.60| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1606.40 | +92.80 | +6.13% |
| R3 | 1570.40 | +56.80 | +3.75% |
| R2 | 1555.20 | +41.60 | +2.75% |
| R1 | 1534.40 | +20.80 | +1.37% |
| PIVOT | 1519.20 | 5.60 | 0.37% |
| CURRENT | 1513.60 | — | — |
| S1 | 1498.40 | -15.20 | -1.00% |
| S2 | 1483.20 | -30.40 | -2.01% |
| S3 | 1462.40 | -51.20 | -3.38% |
| S4 | 1426.40 | -87.20 | -5.76% |
VIJAYA is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹1518.1–₹1540
Trading Below opening range, showing Bearishness
VIJAYA DIAGNOSTIC CEN financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for VIJAYA DIAGNOSTIC CEN — consolidated or standalone — with margins, YoY growth and key ratios inline.
VIJAYA DIAGNOSTIC CEN reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹15,528.09 Cr. and reported EPS of ₹5.16.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 681 | 814 ▲ 19.5% |
| Sales Growth YoY %Derived | 24.39% | 19.49% |
| Other Income | 18 | 21 ▲ 13.5% |
| Total Income | 700 | 835 ▲ 19.3% |
| 85 | 95 ▲ 11.7% | |
| Gross ProfitDerived | 597 | 720 ▲ 20.6% |
| Gross Margin %Derived | 87.56% | 88.37% |
| 323 | 383 ▲ 18.3% | |
| EBITDA (Operating Profit)Derived | 273 | 337 ▲ 23.3% |
| OPM %Derived | 40.10% | 41.38% |
| 96 | 125 ▲ 29.8% | |
| Profit Before Tax (PBT) | 193 | 233 ▲ 20.5% |
| 49 | 60 ▲ 20.9% | |
| Effective Tax %Derived | 25.56% | 25.66% |
| Total Profit for Period | 144 | 173 ▲ 20.3% |
| Less: Non-controlling Interests | 1 | — ▼ 100.0% |
| Net Profit (Owner's PAT)Derived | 143 | 173 ▲ 20.9% |
| Net Profit Margin %Derived | 21.00% | 21.24% |
| PAT Growth YoY %Derived | 20.41% | 20.90% |
| Earnings Per Share (EPS ₹) | 13.94 | 16.81 ▲ 20.6% |
| Diluted Shares Outstanding (Cr) | 10 | 10 ▲ 0.3% |
| Other Comprehensive Income (Net of Tax) | 0 | 1 ▲ 16571.8% |
| Total Expenses (incl. D&A & Interest) | 507 | 602 ▲ 18.9% |
| Material Cost % of RevenueDerived | 12.44% | 11.63% |
| Employee Cost % of RevenueDerived | 16.46% | 16.06% |
| Other Cost % of RevenueDerived | 31.00% | 30.93% |
| Interest Coverage (x)Derived | 7.58x | 7.38x |
| Period | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|
| Revenue from Operations | 462 | 459 ▼ 0.7% | 548 ▲ 19.3% | 681 ▲ 24.4% | 814 ▲ 19.5% | |
| Sales Growth YoY %Derived | — | -0.68% | 19.29% | 24.39% | 19.49% | |
| Other Income | 13 | 14 ▲ 10.3% | 21 ▲ 47.1% | 18 ▼ 12.0% | 21 ▲ 13.5% | |
| Total Income | 475 | 473 ▼ 0.4% | 569 ▲ 20.1% | 700 ▲ 23.1% | 835 ▲ 19.3% | |
71 | 59 ▼ 17.6% | 65 ▲ 11.1% | 85 ▲ 29.5% | 95 ▲ 11.7% | ||
| Gross ProfitDerived | 391 | 400 ▲ 2.4% | 482 ▲ 20.5% | 597 ▲ 23.7% | 720 ▲ 20.6% | |
| Gross Margin %Derived | 84.54% | 87.18% | 88.05% | 87.56% | 88.37% | |
187 | 218 ▲ 16.6% | 261 ▲ 19.8% | 323 ▲ 23.7% | 383 ▲ 18.3% | ||
| EBITDA (Operating Profit)Derived | 204 | 182 ▼ 10.6% | 221 ▲ 21.4% | 273 ▲ 23.7% | 337 ▲ 23.3% | |
| OPM %Derived | 44.05% | 39.64% | 40.32% | 40.10% | 41.38% | |
69 | 83 ▲ 19.6% | 79 ▼ 4.5% | 96 ▲ 22.0% | 125 ▲ 29.8% | ||
| Profit Before Tax (PBT) | 147 | 114 ▼ 23.0% | 159 ▲ 39.8% | 193 ▲ 21.7% | 233 ▲ 20.5% | |
37 | 28 ▼ 22.9% | 39 ▲ 37.9% | 49 ▲ 26.4% | 60 ▲ 20.9% | ||
| Effective Tax %Derived | 24.91% | 24.93% | 24.61% | 25.56% | 25.66% | |
| Total Profit for Period | 111 | 85 ▼ 23.0% | 120 ▲ 40.4% | 144 ▲ 20.2% | 173 ▲ 20.3% | |
| Less: Non-controlling Interests | 1 | 1 ▼ 41.7% | 1 ▲ 41.1% | 1 ▼ 11.5% | — ▼ 100.0% | |
| Net Profit (Owner's PAT)Derived | 110 | 85 ▼ 22.8% | 119 ▲ 40.4% | 143 ▲ 20.4% | 173 ▲ 20.9% | |
| Net Profit Margin %Derived | 23.72% | 18.43% | 21.69% | 21.00% | 21.24% | |
| PAT Growth YoY %Derived | — | -22.84% | 40.40% | 20.41% | 20.90% | |
| Earnings Per Share (EPS ₹) | 10.76 | 8.29 ▼ 23.0% | 11.61 ▲ 40.0% | 13.94 ▲ 20.1% | 16.81 ▲ 20.6% | |
| Diluted Shares Outstanding (Cr) | 10 | 10 ▲ 0.1% | 10 ▲ 0.3% | 10 ▲ 0.3% | 10 ▲ 0.3% | |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▼ 2.4% | -0 ▼ 155.7% | 0 ▲ 103.5% | 1 ▲ 16571.8% | |
| Total Expenses (incl. D&A & Interest) | 328 | 360 ▲ 9.8% | 410 ▲ 13.9% | 507 ▲ 23.6% | 602 ▲ 18.9% | |
| Material Cost % of RevenueDerived | 15.46% | 12.82% | 11.95% | 12.44% | 11.63% | |
| Employee Cost % of RevenueDerived | 15.28% | 17.09% | 16.47% | 16.46% | 16.06% | |
| Other Cost % of RevenueDerived | 25.20% | 30.45% | 31.26% | 31.00% | 30.93% | |
| Interest Coverage (x)Derived | 9.18x | 5.74x | 6.83x | 7.58x | 7.38x |
VIJAYA DIAGNOSTIC CEN segment analysis : revenue and profit mix.
Disclosed business segments at VIJAYA DIAGNOSTIC CEN with their share of revenue and profit, switchable between consolidated and standalone reporting.
VIJAYA DIAGNOSTIC CEN discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for VIJAYA DIAGNOSTIC CEN.
Our AI distills the core fundamental drivers supporting VIJAYA DIAGNOSTIC CEN, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
VIJAYA DIAGNOSTIC CEN's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Valuation risk. a P/E above 108 (~2.3× the sector multiple of 46.8) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 14% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.07%.
VIJAYA DIAGNOSTIC CEN peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — VIJAYA DIAGNOSTIC CEN is highlighted for quick read-across.
Quick Compare
VIJAYA DIAGNOSTIC CEN chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for VIJAYA DIAGNOSTIC CEN — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
VIJAYA DIAGNOSTIC CEN delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for VIJAYA DIAGNOSTIC CEN over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in VIJAYA DIAGNOSTIC CEN stood at 50.9% of traded volume, against a 20-day average of 42.8%.
VIJAYA DIAGNOSTIC CEN announcements: results, concalls, ratings, M&A.
Filings VIJAYA DIAGNOSTIC CEN sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
VIJAYA DIAGNOSTIC CEN files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 165 documents below.
General Updates
Vijaya Diagnostic Centre Limited has informed the Exchange about General Updates - Investor Presentation - 100% Acquisition of integrated diagnostic…
Press Release
Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "100% acquisition of integrated…
Outcome of Board Meeting
Vijaya Diagnostic Centre Limited has informed the Exchange regarding Outcome of Board Meeting held on September 11, 2026. (Approval for execution of…
Analysts/Institutional Investor Meet/Con. Call Updates
Vijaya Diagnostic Centre Limited has informed the Exchange about Schedule of meet
Appointment
Vijaya Diagnostic Centre Limited has informed the Exchange regarding Appointment of Mr Venkata Naresh Yallapragada as Other of the company w.e.f.…
Investor decks & rating reports.
VIJAYA DIAGNOSTIC CEN dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue VIJAYA DIAGNOSTIC CEN has declared, sequenced by announce and record date.
VIJAYA DIAGNOSTIC CEN corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About VIJAYA DIAGNOSTIC CEN: business, sector, key facts.
What VIJAYA DIAGNOSTIC CEN does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
VIJAYA DIAGNOSTIC CEN operates in the Healthcare Service Provider industry under the Healthcare sector, listed as NSE: VIJAYA, BSE: 543350.
Vijaya Diagnostic Centre Limited is a prominent provider of diagnostic healthcare services in India, primarily operating within the country. Their extensive service offerings cater to a wide range of patient needs, encompassing a comprehensive suite of diagnostic tests and imaging procedures.
The core of Vijaya's business lies in its laboratory services. This includes a broad spectrum of clinical pathology tests, microbiology analyses, hematology assessments, serology studies, histopathology examinations, and cytogenetic investigations. Furthermore, they offer advanced biochemical testing and molecular diagnostics, providing a deep and detailed analysis of patient samples.
Beyond laboratory work, Vijaya Diagnostic Centre offers a complete range of sophisticated medical imaging services. This includes Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI) scans, including advanced 3T MRI technology, ultrasound imaging, and X-ray procedures. They also provide specialized imaging services in cardiology, gastroenterology, and nuclear medicine, including Positron Emission Tomography/Computed Tomography (PET/CT) scans.
Complementing its diagnostic services, Vijaya also provides convenient health checkup packages designed for preventative care and early disease detection. The company further enhances accessibility through its home sample collection service, bringing convenience and ease to patients needing diagnostic tests.
Established in 1981 and headquartered in Hyderabad, India, Vijaya Diagnostic Centre Limited has a long history of providing high-quality diagnostic services. Their comprehensive range of offerings, from basic laboratory tests to advanced imaging, positions them as a significant player in the Indian healthcare landscape.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- HEALTH X PLATFORM (HEALTHX) Share PricePeer
- KRSNAA DIAGNOSTICS (KRSNAA) Share PricePeer
- DR LAL PATH LABS (LALPATHLAB) Share PricePeer
- METROPOLIS HEALTHCARE (METROPOLIS) Share PricePeer
- SURAKSHA DIAGNOSTIC (SURAKSHA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top quality scorecard stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about VIJAYA DIAGNOSTIC CEN (VIJAYA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of VIJAYA DIAGNOSTIC CEN (VIJAYA)?
The current share price of VIJAYA DIAGNOSTIC CEN (VIJAYA) is ₹1,513.60. Today, the stock has declined by ₹12.90 (0.85%), trading in a range of ₹1,504.00 to ₹1,540.00. The stock opened at ₹1,528.00 with a trading volume of 58,184 shares.
02Is VIJAYA DIAGNOSTIC CEN stock a good investment for long-term?
VIJAYA DIAGNOSTIC CEN can be considered for long-term investment based on several factors. The company has a market capitalization of ₹15,528.09 Cr., P/E ratio of 82.71, ROE of 18.9%, and ROCE of 22.25%. The dividend yield stands at 0.13%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of VIJAYA DIAGNOSTIC CEN stock?
The 52-week high price of VIJAYA DIAGNOSTIC CEN (VIJAYA) is ₹1,593.60, while the 52-week low is ₹848.00. Currently trading at ₹1,513.60, the stock is 78.49% above its 52-week low and 5.02% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy VIJAYA DIAGNOSTIC CEN stock at the current price?
Whether to buy VIJAYA DIAGNOSTIC CEN stock at ₹1,513.60 depends on multiple factors. The stock is currently trading with a P/E ratio of 82.71 and P/B ratio of 16.21. Today's performance shows a loss of 0.85%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of VIJAYA DIAGNOSTIC CEN and when is the next dividend?
VIJAYA DIAGNOSTIC CEN offers a dividend yield of 0.13%, which means for every ₹100 invested at the current price of ₹1,513.60, you can expect to receive approximately ₹0.13 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of VIJAYA DIAGNOSTIC CEN?
VIJAYA DIAGNOSTIC CEN's key financial metrics include: P/E Ratio: 82.71, P/B Ratio: 16.21, ROE: 18.9%, ROCE: 22.25%, Dividend Yield: 0.13%, EPS: ₹5.16, Book Value: ₹92.94, and Debt-to-Equity: 0. The company's market cap stands at ₹15,528.09 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is VIJAYA DIAGNOSTIC CEN stock performing today in the market?
VIJAYA DIAGNOSTIC CEN stock opened at ₹1,528.00 and is currently trading at ₹1,513.60, showing a decline of ₹12.90 (0.85%). The intraday high is ₹1,540.00 and low is ₹1,504.00. The trading volume stands at 58,184 shares, indicating moderate market participation today.
08What is the P/E ratio of VIJAYA DIAGNOSTIC CEN and what does it indicate?
VIJAYA DIAGNOSTIC CEN has a Price-to-Earnings (P/E) ratio of 82.71, which means investors are willing to pay 82.71 for every ₹1 of earnings. With an EPS of ₹5.16, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about VIJAYA DIAGNOSTIC CEN (VIJAYA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.